Literature DB >> 19829004

Role of seminiferous tubular development in determining the FSH versus LH responsiveness to GnRH in early sexual maturation.

Nelly Pitteloud1, Apisadaporn Thambundit, Andrew A Dwyer, John L Falardeau, Lacey Plummer, Lisa M Caronia, Frances J Hayes, Hang Lee, Paul A Boepple, William F Crowley.   

Abstract

BACKGROUND: The onset of sexual maturation at puberty is a unique developmental period from a neuroendocrine perspective in that it is characterized by enhanced FSH secretion and FSH responsiveness to exogenous GnRH (vs. LH) from the gonadotrope, yet the mechanism of these dynamics remains unclear. This study aimed to elucidate this phenomenon using a human disease model of GnRH deficiency (idiopathic hypogonadotropic hypogonadism, IHH) in which GnRH input can be experimentally controlled.
METHODS: 25 GnRH-deficient men were selected for study based upon their baseline testicular volumes (TV) and serum inhibin B (I(B)) levels to represent a spectrum of pubertal/testicular development. Subjects underwent: (i) a 12-hour overnight neuroendocrine evaluation for hormonal profiling and determination of endogenous LH secretion pattern, and (ii) a 7-day exposure to a physiologic regimen of exogenous pulsatile GnRH (25 ng/kg every 2 h). Daily measurements of serum testosterone (T) and I(B) levels were made and a 2-hour window of frequent blood sampling was monitored to measure LH and FSH following a single i.v. GnRH bolus (25 ng/kg). All subjects were screened for known loci underlying GnRH deficiency and the response to GnRH was tracked according to genotype.
RESULTS: Among the entire cohort, no changes were noted in serum T or I(B) during the 7 days, thus keeping gonadal feedback relatively constant. However, serum LH and FSH levels increased significantly (p < 0.0001) in the entire cohort. When analyzed by degree of pubertal/testicular development, men with no evidence of prior spontaneous pubertal development (TV <or=3 ml, Group I) showed sharp increases in serum FSH compared to men with some prior evidence of partial puberty (TV >3 ml, Group II, p < 0.0001). Group I exhibited a decreased LH response to GnRH on day 2 compared to day 1 (p < 0.01), which did not recover until day 5 (1-4 vs. 5-7 days, p < 0.0001). Group II displayed robust and equivalent LH responses to GnRH throughout the 7-day study. Genetic studies identified 8 mutations in 4 different loci (DAX1, KAL1, GNRHR, and FGFR1) in this cohort.
CONCLUSIONS: GnRH-deficient men undergoing GnRH-induced sexual maturation display an inverse relationship between FSH responsiveness to GnRH and baseline testicular size and I(B) levels. This observation implies that increasing seminiferous tubule maturity represents the major constraint on FSH responsiveness to GnRH in early puberty. In contrast, LH responsiveness to GnRH correlates directly with duration of GnRH exposure. Attenuated pituitary gonadotropin responses were noted in subjects harboring DAX1 mutations, consistent with known pituitary defects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19829004      PMCID: PMC2826435          DOI: 10.1159/000245383

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  47 in total

1.  Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism.

Authors:  Nelly Pitteloud; Frances J Hayes; Andrew Dwyer; Paul A Boepple; Hang Lee; William F Crowley
Journal:  J Clin Endocrinol Metab       Date:  2002-09       Impact factor: 5.958

Review 2.  Inhibins in normal male physiology.

Authors:  Anne E O'Connor; David M De Kretser
Journal:  Semin Reprod Med       Date:  2004-08       Impact factor: 1.303

3.  Mutational analysis of DAX1 in patients with hypogonadotropic hypogonadism or pubertal delay.

Authors:  J C Achermann; W X Gu; T J Kotlar; J J Meeks; L P Sabacan; S B Seminara; R L Habiby; P C Hindmarsh; D P Bick; R J Sherins; W F Crowley; L C Layman; J L Jameson
Journal:  J Clin Endocrinol Metab       Date:  1999-12       Impact factor: 5.958

4.  Reversible kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene.

Authors:  Nelly Pitteloud; James S Acierno; Astrid U Meysing; Andrew A Dwyer; Frances J Hayes; William F Crowley
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

5.  The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics.

Authors:  L M Oliveira; S B Seminara; M Beranova; F J Hayes; S B Valkenburgh; E Schipani; E M Costa; A C Latronico; W F Crowley; M Vallejo
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

6.  The fertile eunuch variant of idiopathic hypogonadotropic hypogonadism: spontaneous reversal associated with a homozygous mutation in the gonadotropin-releasing hormone receptor.

Authors:  N Pitteloud; P A Boepple; S DeCruz; S B Valkenburgh; W F Crowley; F J Hayes
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

7.  The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism.

Authors:  Nelly Pitteloud; Frances J Hayes; Paul A Boepple; Suzzunne DeCruz; Stephanie B Seminara; David T MacLaughlin; William F Crowley
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

8.  Testicular size: assessment and clinical importance.

Authors:  A Prader
Journal:  Triangle       Date:  1966

9.  The GPR54 gene as a regulator of puberty.

Authors:  Stephanie B Seminara; Sophie Messager; Emmanouella E Chatzidaki; Rosemary R Thresher; James S Acierno; Jenna K Shagoury; Yousef Bo-Abbas; Wendy Kuohung; Kristine M Schwinof; Alan G Hendrick; Dirk Zahn; John Dixon; Ursula B Kaiser; Susan A Slaugenhaupt; James F Gusella; Stephen O'Rahilly; Mark B L Carlton; William F Crowley; Samuel A J R Aparicio; William H Colledge
Journal:  N Engl J Med       Date:  2003-10-23       Impact factor: 91.245

10.  Differential regulation of gonadotropin subunit gene promoter activity by pulsatile gonadotropin-releasing hormone (GnRH) in perifused L beta T2 cells: role of GnRH receptor concentration.

Authors:  Grégoy Y Bédécarrats; Ursula B Kaiser
Journal:  Endocrinology       Date:  2003-05       Impact factor: 4.736

View more
  4 in total

Review 1.  Hypogonadotropic hypogonadism in subjects with DAX1 mutations.

Authors:  Unmesh Jadhav; Rebecca M Harris; J Larry Jameson
Journal:  Mol Cell Endocrinol       Date:  2011-06-13       Impact factor: 4.102

2.  Predictive factors for pituitary response to pulsatile GnRH therapy in patients with congenital hypogonadotropic hypogonadism.

Authors:  Jiang-Feng Mao; Xi Wang; Jun-Jie Zheng; Zhao-Xiang Liu; Hong-Li Xu; Bing-Kun Huang; Min Nie; Xue-Yan Wu
Journal:  Asian J Androl       Date:  2018 Jul-Aug       Impact factor: 3.285

3.  SOX2 regulates the hypothalamic-pituitary axis at multiple levels.

Authors:  Sujatha A Jayakody; Cynthia L Andoniadou; Carles Gaston-Massuet; Massimo Signore; Anna Cariboni; Pierre M Bouloux; Paul Le Tissier; Larysa H Pevny; Mehul T Dattani; Juan P Martinez-Barbera
Journal:  J Clin Invest       Date:  2012-09-04       Impact factor: 14.808

4.  Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy in patients with congenital hypogonadotropic hypogonadism: a multicentre clinical study.

Authors:  Ming Hao; Jiang-Feng Mao; Qing-Bo Guan; Long Tian; Hu Han; Hong-En Lei; Dong-Mei Zheng; Zhen-Hua Tian; Min Nie; Xi Wang; Bing-Qing Yu; Yin-Jie Gao; Xue-Yan Wu
Journal:  Ann Transl Med       Date:  2021-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.